Apoptotic/mytogenic pathways during human heart development

International Journal of Cardiology

Volumn 96, Issue 3, 2004, Pages 409-417

  Fiorina, Paolo ^a   Corradi, Domenico ^b   Pinelli, Silvana ^b   Maestri, Roberta ^b   Lagrasta, Costanza ^b   Buscaglia, Mauro ^c   Davalli, Alberto ^a   Folli, Franco ^a   Astorri, Ettore ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Apoptosis; Heart development; Myocardial infarction; Myocytes

Indexed keywords

FAS ANTIGEN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; GESTATIONAL AGE; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HISTOLOGY; HUMAN; HUMAN TISSUE; MITOSIS; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; CELL PROLIFERATION; FEMALE; FETAL HEART; GESTATIONAL AGE; HEART; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MONOCYTES; MYOCARDIUM; PHOSPHORYLATION;

EID: 4143090549     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.08.010     Document Type: Article

References (48)

1. Pexieder T. Cell Death in the Morphogenesis of the Heart. 1975;Springer-Verlag, New York
2. MacLellan W.R., Schneider M.D. Death by design programmed cell death in cardiovascular biology and disease. Circ. Res. 81:1997;137-144
3. James T.N. Normal and abnormal consequences of apotosis in the human heart from postnatal morphogenesis to proximal arrhythmias. Circulation. 90:1994;556-573
4. Abdulla R. Apoptosis: is cell death a crucial step in cardiac development? Pediatr. Cardiol. 18:1997;308
5. Kajstura J., Mansukhani M., Cheng W., et al. Programmed cell death and expression of the protooncogene Bcl-2 in myocytes during postnatal maturation of the heart. Exp. Cell Res. 219:1995;110-121
6. Abdelwahid E., Pelliniemi L.J., Niinikoski H., et al. Apoptosis in the pattern formation of the ventricular wall during mouse heart organogenesis. Anat. Rec. 256:1999;208-217
7. Fisher S.A., Langille B.L., Srivastava D. Apoptosis during cardiovascular development. Circ. Res. 87:2000;856-864
8. Brömme H.J., Holtz J. Apoptosis in the heart: when and why? Mol. Cell. Biochem. 163/164:1997;261-275
9. Chittenden T., Harrington E.A., O'Connor R., et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736
10. Schmitz I., Walczak H., Krammer P.H., Peter M.E. Differences between CD95 type I and II cells detected with the CD95 ligand. Cell Death Differ. 6:1999;821-822
11. Ryo K., Kamogawa Y., Ikeda I., et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am. J. Gastroenterol. 95:2000;2047-2055
12. O'Connor L., Harris A.W., Strasser A. CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types. Cancer Res. 60:2000;1217-1220
13. Pelicci G., Lanfrancone L., Grignani F., et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 70:1992;93
14. Lanfrancone L., Pelicci G., Brizzi M.F., et al. Overexpression of Shc proteins potentiates the proliferative response to the granulocytemacrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the b receptor subunit. Oncogene. 10:1995;907
15. Salcini A.E., McGlade J., Pelicci G., Nicoletti I., Pawson T., Pelicci P.G. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene. 9:1994;2827
16. Pelicci G., Lanfrancone L., Salcini A.E., et al. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene. 11:1995;899
17. Thorburn J., Xu S., Thorburn A. MAP kinase and Rho dependent signals interact to regniate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 16:1997;1888-1900
18. Lai K.M., Pawson T. The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev. 14:2000;1132-1145
19. Ravichandran K.S. Signaling via Shc family adapter proteins. Oncogene. 20:2001;6322-6330
20. Bokemeyer D., Sorokin A., Dunn M.J. Multiple intracellular MAP kinase signaling cascades. Kidney Int. 49:1996;1187-1198
21. Bokemeyer D., Guglielmi E., McGinty A., et al. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J. Clin. Invest. 100:1997;582-588
22. Mizukami Y., Yoshioka K., Morimoto S., Yoshida Ki. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J. Biol. Chem. 272:1997;16657-16662
23. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331
24. Bonati A., Carlo-Stella C., Lunghi P., Albertini R., Pinelli S., Migliaccio E., et al. Selective expression and constitutive phosphorylation of SHC proteins in the CD34+ fraction of chronic myelogenous leukemias. Cancer Res. 60:2000;728-732
25. Olivetti G., Quaini F., Sala R., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J. Mol. Cell Cardiol. 28:1996;2005-2016
26. Zac R. Cell proliferating during the cardiac growth. Am. J. Cardiol. 31:1973;211-219
27. Zac R. Dévelopement and proliferative capacity of cardiac muscle cells. Circ. Res. 34-35(Suppl. II):1974;17-25
28. Manasek F.J. Embryonic developement of the heart. 1. A light and electron microscopic study of myocardial development in the early chick embryo. J. Morphol. 125:1968;329-366
29. Anversa P., Olivetti G., Loud A.V. Morphometric study of early postnatal developement in the left and right ventricular myocardium of the rat: I. Hypertrophy, hyperplasia, and binucleation of myocytes. Circ. Res. 46:1980;496-502
30. Roberts W.C., Siegel R.J., McManus B.M. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am. J. Cardiol. 60:1987;1340-1355
31. Beltrami C.A., Finato N., Rocco M., et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 89:1994;151-163
32. Beltrami C.A., Finato N., Rocco M., et al. The cellular basis of dilated cardiomyopathy in humans. J. Mol. Cell. Cardiol. 27:1995;291-305
33. Anversa P., Beghi C., Kikkawa Y., Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ. Res. 58:1986;26-37
34. Astorri E., Bolognesi R., Colla B., Chizzola A., Visioli O. Left ventricular hypertrophy: a cytometric study on 42 human hearts. J. Mol. Cell. Cardiol. 9:1977;763-775
35. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8801-8805
36. Haanen C., Vermes I. Apoptosis: programmed cell death in fetal development. Eur. J. Obstet. Gynecol. Reprod. Biol. 64:1996;129-133
37. Takeda K., Yu Z.Y., Nishikawa T., et al. Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J. Mol. Cell. Cardiol. 28:1996;209-215
38. Xavier-Vidal R., Mandarim-de-Lacerda C.A. Cardiomyocyte proliferation and hypertrophy in the human fetus: quantitative study of the myocyte nuclei. Bull. Assoc. Anat. (Nancy). 79:1995;27-31
39. Anversa P., Ricci R., Olivetti G. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J. Am. Coll. Cardiol. 7:1986;1140-1149
40. Owen-Lynch P.J., Wong A.K.Y., Whetton A.D. v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;5956-5962
41. Beltrami A.P., Urbanek K., Kajstura J., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344:2001;1750-1757
42. Laderoute K.R., Webster K.A. Hypoxia/reoxigenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ. Res. 80:1997;336-344
43. Tanaka M., Ito H., Adachi S., et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messanger RNA in cultured neonatal rat cardiomyocites. Circ. Res. 75:1994;426-433
44. Watanabe F.R., Brannan C.I., Itoh N., et al. The cDNA structure expression, and chromosomal assignement of the mouse Fas antigen. J. Immunol. 148:1992;1274-1279
45. Itoh N., Yonehara S., Ishii A., et al. The polypeptide encoded bv the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-423
46. Nakamura T., Sanokawa R., Sasaki Y., Ayusawa D., Oishi M., Mori N. N-Shc: a neuronal-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Oncogene. 13:1996;1111-1121
47. shc and p66 splicing isoforms on the EGF receptor-MAP kinase-fos signaling pathway. EMBO J. 16:1997;706
48. Wary K.K., Mainiero F., Isakoff S.J., Marcantonio E.E., Giancotti F.G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell. 87:1996;733